SE435290B - Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat - Google Patents
Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylatInfo
- Publication number
- SE435290B SE435290B SE7602565A SE7602565A SE435290B SE 435290 B SE435290 B SE 435290B SE 7602565 A SE7602565 A SE 7602565A SE 7602565 A SE7602565 A SE 7602565A SE 435290 B SE435290 B SE 435290B
- Authority
- SE
- Sweden
- Prior art keywords
- alfa
- yltiomethyl
- cefem
- phenylacetamido
- formyloxy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Cephalosporin Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/567,324 US4006138A (en) | 1975-04-11 | 1975-04-11 | Crystalline form of sodium O-formylcefamandole |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| SE7602565L SE7602565L (sv) | 1976-10-12 |
| SE435290B true SE435290B (sv) | 1984-09-17 |
Family
ID=24266692
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SE7602565A SE435290B (sv) | 1975-04-11 | 1976-02-26 | Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US4006138A (de) |
| JP (1) | JPS51123812A (de) |
| AR (1) | AR210880A1 (de) |
| AT (1) | AT343806B (de) |
| AU (1) | AU500013B2 (de) |
| BE (1) | BE840179A (de) |
| CA (1) | CA1045114A (de) |
| CH (1) | CH621554A5 (de) |
| CS (1) | CS191970B2 (de) |
| DD (1) | DD125950A5 (de) |
| DE (1) | DE2614669C2 (de) |
| DK (1) | DK148022C (de) |
| ES (1) | ES446907A1 (de) |
| FI (1) | FI65069C (de) |
| FR (1) | FR2306698A1 (de) |
| GB (1) | GB1546898A (de) |
| GR (1) | GR59912B (de) |
| HU (1) | HU175592B (de) |
| IL (1) | IL49100A (de) |
| LU (1) | LU74740A1 (de) |
| MX (1) | MX3687E (de) |
| NL (1) | NL184258C (de) |
| NO (1) | NO151748C (de) |
| OA (1) | OA05290A (de) |
| PL (1) | PL104803B1 (de) |
| PT (1) | PT64917B (de) |
| RO (1) | RO68501A (de) |
| SE (1) | SE435290B (de) |
| SU (1) | SU668608A3 (de) |
| YU (1) | YU40643B (de) |
| ZA (1) | ZA761103B (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SE7503274L (sv) * | 1974-04-11 | 1975-10-13 | Ciba Geigy Ag | Cefalosporin |
| US4085277A (en) * | 1975-01-30 | 1978-04-18 | Fujisawa Pharmaceutical Co., Ltd. | 7(2-Phenyl or thienyl-2-isonicotinoyloxyacetamido)-3-(1-methyl-1-H tetrazol-5-yl)thiomethyl-3-cephem-4-carboxylic acid |
| FR2400519A1 (fr) * | 1977-08-17 | 1979-03-16 | Roussel Uclaf | Forme cristalline du sel de sodium d'un derive oximine de l'acide 7-amino-thiazolyl acetamido cephalosporanique, son procede de preparation et son application comme medicament |
| US4168376A (en) * | 1978-06-05 | 1979-09-18 | Eli Lilly And Company | Process for crystalline sodium cefamandole |
| US4946838A (en) * | 1981-07-13 | 1990-08-07 | E. R. Squibb & Sons, Inc. | Crystalline anhydrous aztreonam |
| EP0432297A1 (de) * | 1989-12-13 | 1991-06-19 | Technologitschen Kombinat Sa Promischlena Mikrobiologia | Verfahren zur Herstellung des Natriumsalzes von O-formylcefamandol |
| US5492903A (en) * | 1990-06-19 | 1996-02-20 | Takeda Chemical Industries Ltd. | Crystalline esters of (+)-(5R, 6S)-6-[(R)-1-hydroxyethyl]-3-(3-pyridyl)-7-oxo-4-thia-1-azabicyclo[3.2.0]he |
| US7842791B2 (en) * | 2002-12-19 | 2010-11-30 | Nancy Jean Britten | Dispersible pharmaceutical compositions |
| WO2013057196A1 (en) * | 2011-10-20 | 2013-04-25 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Process for the preparation of cefamandole nafate |
| CN104530086B (zh) * | 2014-12-16 | 2015-12-09 | 天津大学 | 头孢孟多酯钠化合物的新晶型及其结晶制备方法 |
| CN105037392A (zh) * | 2015-08-13 | 2015-11-11 | 青岛蓝盛洋医药生物科技有限责任公司 | 一种杀菌药物头孢孟多酯钠化合物及其制备方法 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3887551A (en) * | 1964-11-04 | 1975-06-03 | Glaxo Lab Ltd | Crystalline forms of cephaloridine |
| US3641021A (en) * | 1969-04-18 | 1972-02-08 | Lilly Co Eli | 3 7-(ring-substituted) cephalosporin compounds |
-
1975
- 1975-04-11 US US05/567,324 patent/US4006138A/en not_active Expired - Lifetime
-
1976
- 1976-02-24 ZA ZA761103A patent/ZA761103B/xx unknown
- 1976-02-24 CA CA246,497A patent/CA1045114A/en not_active Expired
- 1976-02-24 GR GR50143A patent/GR59912B/el unknown
- 1976-02-25 IL IL49100A patent/IL49100A/xx unknown
- 1976-02-26 SE SE7602565A patent/SE435290B/xx not_active IP Right Cessation
- 1976-02-26 AU AU11435/76A patent/AU500013B2/en not_active Expired
- 1976-03-09 AR AR262491A patent/AR210880A1/es active
- 1976-03-18 PT PT64917A patent/PT64917B/pt unknown
- 1976-03-23 NO NO761017A patent/NO151748C/no unknown
- 1976-03-24 FI FI760788A patent/FI65069C/fi not_active IP Right Cessation
- 1976-03-26 YU YU792/76A patent/YU40643B/xx unknown
- 1976-03-27 OA OA55785A patent/OA05290A/xx unknown
- 1976-03-30 BE BE1007290A patent/BE840179A/xx not_active IP Right Cessation
- 1976-03-31 DK DK150676A patent/DK148022C/da not_active IP Right Cessation
- 1976-03-31 FR FR7609361A patent/FR2306698A1/fr active Granted
- 1976-04-01 JP JP51036673A patent/JPS51123812A/ja active Granted
- 1976-04-01 RO RO7685381A patent/RO68501A/ro unknown
- 1976-04-05 DE DE2614669A patent/DE2614669C2/de not_active Expired
- 1976-04-06 CS CS762264A patent/CS191970B2/cs unknown
- 1976-04-07 GB GB14020/76A patent/GB1546898A/en not_active Expired
- 1976-04-07 NL NLAANVRAGE7603660,A patent/NL184258C/xx not_active IP Right Cessation
- 1976-04-07 SU SU762343056A patent/SU668608A3/ru active
- 1976-04-08 AT AT258476A patent/AT343806B/de not_active IP Right Cessation
- 1976-04-09 HU HU76EI673A patent/HU175592B/hu unknown
- 1976-04-09 LU LU74740A patent/LU74740A1/xx unknown
- 1976-04-09 MX MX76161U patent/MX3687E/es unknown
- 1976-04-09 CH CH455376A patent/CH621554A5/de not_active IP Right Cessation
- 1976-04-09 DD DD192287A patent/DD125950A5/xx unknown
- 1976-04-10 PL PL1976188683A patent/PL104803B1/pl unknown
- 1976-04-10 ES ES446907A patent/ES446907A1/es not_active Expired
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE433208B (sv) | Forfarande for framstellning av fenoletrar | |
| NO144209C (no) | Fremgangsmaate for fremstilling av dialkylkarbonater | |
| NO148712C (no) | Fremgangsmaate ved fremstilling av etylidendiacetat | |
| SE431088B (sv) | Forfarande for framstellning av terapeutiskt verksamma benshydrylsulfinylderivat | |
| SE7605139L (sv) | Forfarande for framstellning av vattenupptagande cellulosaetrar | |
| SE7601390L (sv) | Forfarande for framstellning av kiselorganiska kompositioner | |
| SE430336B (sv) | Forbettrat forfarande for framstellning av amoxicillinfrihydrat | |
| SE433610B (sv) | Forfarande for framstellning av aromatiska uretaner | |
| AR217629A1 (es) | Procedimiento de preparacion de derivados de tienotetrahidropiridina | |
| SE435290B (sv) | Forfarande for framstellning av gamma-kristallin form av natrium-7-(d-alfa-formyloxi-alfa-fenylacetamido)-(2-metyl-1h-tetrazol-5-yltiometyl)-3-cefem-4-karboxylat | |
| SE7607717L (sv) | Analogiforfarande for framstellning av l-pyroglutamyl-l-prolinamid | |
| NO139555C (no) | Fremgangsmaate for fremstilling av fosgen | |
| SE7606116L (sv) | Forfarande for framstellning av 3-fenoxidbensaldehyder | |
| SE7604781L (sv) | Forfarande for framstellning av diarylhydroxibutylaminer | |
| SE409455B (sv) | Analogiforfarande for framstellning av nitroimidazolyl-kinazolinderivat | |
| SE404186B (sv) | Forfarande for framstellning av cyklopropanolderivat | |
| SE423814B (sv) | Forfarande for framstellning av dibensofenazin- eller acenaftokinoxalinderivat | |
| SE7604669L (sv) | Forfarande for framstellning av estrar av tiokarbamidsyror | |
| SE446726B (sv) | Forfarande for framstellning av 16-metoxiprostaglandiner | |
| SE7610637L (sv) | Forfarande for framstellning av 2-alkylindaner | |
| SE7608589L (sv) | Forfarande for framstellning av fortimicin c | |
| SE7604940L (sv) | Forfarande for framstellning av sulfamylbensoesyror | |
| SE7607026L (sv) | Forfarande for framstellning av 5-alkylpikolinsyra | |
| SE7605427L (sv) | Forfarande for framstellning av klorcyan | |
| SE7603682L (sv) | Forfarande for framstellning av en eteriskt substituerad monosackarid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| NAL | Patent in force |
Ref document number: 7602565-9 Format of ref document f/p: F |
|
| NUG | Patent has lapsed |
Ref document number: 7602565-9 Format of ref document f/p: F |